Immunology Biosimilars Market Size, Share & Industry Analysis, By Drug Class (TNF-alpha Inhibitors, Interleukin Inhibitors, B-cell/Anti-CD20 Therapies, and Anti-IgE Therapies), By Product (Adalimumab, Infliximab, Etanercept, Rituximab, and Ustekinumab Biosimilars), By Indication (Rheumatology, Gastroenterology, Dermatology, and Allergy & Clinical Immunology), By Age Group (Pediatric and Adults), By Route of Administration (Subcutaneous and Intravenous), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, and Retail & Online Pharmacies), and Regional Forecast, 2026-2034